<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>24108344</identifier>
<setSpec>0016-3813</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Oliva-Sánchez, Pablo Francisco</dc:author>
<dc:author>Jafif-Cojab, Marcos</dc:author>
<dc:author>Waliszewski-Zamorano, Esteban</dc:author>
<dc:author>Akkad-Schaffer, Isaac</dc:author>
<dc:description xml:lang="en">Mexico has entered an era where health research is enriched by the study of genetic variants that determinate how the different human populations are differentially susceptible to diseases. The objective is to design new strategies in health care and services based on medical genomics. However, to ensure universal access to these products, we should rethink the legal aspects that facilitate the design of health policies, based on the principle of equity. Intrinsic factors of the Mexican health system as inequity, poverty and low investment in health research, are challenges that add to the development of appropriate distribution strategies for the use of new genomic products for health. This article discusses these challenges and establish the basis to design policies and appropriate use of these new genomic-based health care services.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>2013 Sep-Oct </dc:date>
<dc:title xml:lang="es">Equidad, salud pública y genómica: el reto jurídico, social y biotecnológico en México.</dc:title>
<dc:title xml:lang="en">[Equity, public health and genomics: the legal, social and biotechnology challenge in México].</dc:title>
<dc:publisher>Gaceta medica de Mexico</dc:publisher>
</metadata>
</record>
</pubmed-document>
